Global X S&P Biotech ETF is a sector & thematic ETF from Global X — 157 holdings, with $39.6m under management. 75% of its money is in health care. Its two largest holdings, MODERNA INC and TWIST BIOSCIENCE, make up 4% of the fund. It charges 0.45% a year.
Compare CURE with another fund →NKTR
NEKTAR THERAPEUT
Health Care · United States · 0.21% of CURE on average
Contributed −$18 per $10k to CURE over the last month.
Loading…
Explained moves, and what each did to CURE
About CURE
- TypeSector & thematic
- IssuerGlobal X
- Size$39.6m
- Cost0.45% a year
- Holdings157
- Top sectorHealth Care 75%
- Top 2 holdings4%
CURE fell 5.6% over the last month. On $10,000, that's −$561. QURE was the biggest drag at −$44; MRNA helped most at +$83.
What moved it
Gain or loss per $10k invested
- MRNAModerna+$83
- GRALGrail+$61
- IOVAIovance+$54
- QUREUniqure−$44
- TWSTTwist+$41
- ARWRArrowhead−$37
- PRAXPraxis−$35
- DNTHDianthus−$33
- CELCCelcuity−$31
- DYNDyne−$30
- TVTXTravere−$29
- INSMInsmed−$28
- NTRANatera+$27
- SRRKScholar Rock−$26
- VKTXViking−$25
- BMRNBiomarin−$25
- ORKAOruka−$24
- MIRMMirum−$21
- IBRXImmunitybio+$21
- IONSIonis Pharma−$21
- SLSSellas Life−$21
- IMVTImmunovant−$19
- CYTKCytokinetics−$18
- ALNYAlnylam Pharma−$18
- NKTRNektar−$18
- SYRESpyre−$16
- CRSPCrispr−$16
- INCYIncyte−$15
- REGNRegeneron−$15
- RVMDRevolution−$15
- KRYSKrystal−$10
- VRTXVertex Pharma−$10
- KYMRKymera−$8
- ABBVAbbVie+$8
- TGTXTg Thera.−$7
- AMGNAmgen−$7
- PTGXProtagonist−$5
- ROIVRoivant−$4
- GILDGilead−$3
- EXELExelixis+$1
- BIIBBiogen−$1
- HALOHalozyme−$0
- UnattributedFX, hedging, fees, timing−$19
- CompoundingDaily returns multiply, they do not add−$16
- Fund return−$561
- Other 8 kinds of news−$20
- Other 6 kinds of news+$17
Each kind of news counts the days those moves happened; No flagged news is every other day. News is tracked for moves large enough to be flagged; most international holdings had none in this range.